Sitalvi 25/50/100 mg (Sitagliptin)

Sitalvi 25/ 50/ 100 mg (Sitagliptin)

Drug Form: Tablets

Sitagliptin is a type 4 Dipeptidyl-peptidase enzyme inhibitor (DPP-4), which is an oral antidiabetic agent and helps to control blood sugar by controlling insulin levels. Sitagliptin regulates the amount of insulin produced by the body after eating. Sitagliptin is used alone or as a adjuvant therapy in the treatment of type 2 diabetes and is not useful in the treatment of type 1 diabetes.